Tertiary lymphoid structures gene signature predicts response to immunotherapy plus chemotherapy in advanced non-small cell lung cancer

Abstract Background Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality, with chemoimmunotherapy (CIT) as the first-line standard for advanced NSCLC without driver mutations. However, predictive biomarkers for CIT response are limited. Tertiary lymphoid structures...

全面介紹

書目詳細資料

Principais autores:	Wei Du, Bijing Xiao, Xuan Yang, Jianhua Zhan, Haishuang Sun, Yunpeng Yang, Wenfeng Fang, Yan Huang, Dongchen Sun, Shaodong Hong, Li Zhang
格式:	Artigo
語言:	Inglês
出版:	Springer 2025-09-01
叢編:	Cancer Immunology, Immunotherapy
主題:	Non-small cell lung cancer Platinum-based chemotherapy combined with immunotherapy First-line Tertiary lymphoid structures
在線閱讀:	https://doi.org/10.1007/s00262-025-04165-2
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!